Mural Oncology (MURA) Ownership - Who owns Mural Oncology?
Mural Oncology PLC is a clinical-stage oncology company whose entire business is focused on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer... Show more
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. MURA showed earnings on August 04, 2025. You can read more about the earnings report here.